Spremljaj
Benjamin Meyer
Benjamin Meyer
Group leader, University of Geneva
Preverjeni e-poštni naslov na unige.ch
Naslov
Navedeno
Navedeno
Leto
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
S Stringhini, A Wisniak, G Piumatti, AS Azman, SA Lauer, H Baysson, ...
The Lancet 396 (10247), 313-319, 2020
12152020
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
CBEM Reusken, BL Haagmans, MA Müller, C Gutierrez, GJ Godeke, ...
The Lancet infectious diseases 13 (10), 859-866, 2013
9382013
Serological assays for emerging coronaviruses: challenges and pitfalls
B Meyer, C Drosten, MA Müller
Virus research 194, 175-183, 2014
5092014
Human betacoronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe
A Annan, HJ Baldwin, VM Corman, SM Klose, M Owusu, EE Nkrumah, ...
Emerging infectious diseases 19 (3), 456, 2013
4982013
Transmission of MERS-coronavirus in household contacts
C Drosten, B Meyer, MA Müller, VM Corman, M Al-Masri, R Hossain, ...
New England Journal of Medicine 371 (9), 828-835, 2014
4852014
Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
VM Corman, AM Albarrak, AS Omrani, MM Albarrak, ME Farah, M Almasri, ...
Clinical Infectious Diseases 62 (4), 477-483, 2016
4782016
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
VM Corman, MA Müller, U Costabel, J Timm, T Binger, B Meyer, P Kreher, ...
Eurosurveillance 17 (49), 20334, 2012
4782012
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
ZA Memish, M Cotten, B Meyer, SJ Watson, AJ Alsahafi, AA Al Rabeeah, ...
Emerging infectious diseases 20 (6), 1012, 2014
4502014
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies
S Gierer, S Bertram, F Kaup, F Wrensch, A Heurich, A Krämer-Kühl, ...
Journal of virology 87 (10), 5502-5511, 2013
4152013
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ...
Nature 524 (7563), 97-101, 2015
3842015
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997
MA Müller, VM Corman, J Jores, B Meyer, M Younan, A Liljander, ...
Emerging infectious diseases 20 (12), 2093, 2014
3812014
Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013
B Meyer, MA Müller, VM Corman, CBEM Reusken, D Ritz, GJ Godeke, ...
Emerging infectious diseases 20 (4), 552, 2014
3682014
SARS-CoV-2 viral load and shedding kinetics
O Puhach, B Meyer, I Eckerle
Nature Reviews Microbiology 21 (3), 147-161, 2023
3652023
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
MA Müller, B Meyer, VM Corman, M Al-Masri, A Turkestani, D Ritz, ...
The Lancet Infectious Diseases 15 (5), 559-564, 2015
3362015
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
O Puhach, K Adea, N Hulo, P Sattonnet, C Genecand, A Iten, ...
Nature medicine 28 (7), 1491-1500, 2022
3222022
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013
VM Corman, J Jores, B Meyer, M Younan, A Liljander, MY Said, I Gluecks, ...
Emerging infectious diseases 20 (8), 1319, 2014
2862014
Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
C Reusken, M Ababneh, S Raj, B Meyer, A Eljarah, S Abutarbush, ...
Eurosurveillance 18 (50), 2013
2772013
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ...
The Lancet Infectious Diseases 21 (4), e69-e70, 2021
2532021
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines
MA Müller, VS Raj, D Muth, B Meyer, S Kallies, SL Smits, R Wollny, ...
MBio 3 (6), 10.1128/mbio. 00515-12, 2012
2372012
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1
Y Ma-Lauer, J Carbajo-Lozoya, MY Hein, MA Müller, W Deng, J Lei, ...
Proceedings of the National Academy of Sciences 113 (35), E5192-E5201, 2016
2362016
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20